Feb 2, 2024 | News
As part of its strategic growth, the Life Sciences industry and technology consultancy firm headquartered in Verona (Italy), recruits Massimo Raineri as Senior Consultant, Clinical Business Partner.
Where Arithmos currently is as a company
Arithmos has undergone a dynamic transformation and expansion in the last year, consistently prioritizing the enhancement of the value proposition for its customers.
The consolidation of Arithmos in a single group, including consultancy, technology and services as value proposition plays a crucial role in the refined strategic direction of Arithmos in the Life Science industry. Operating across Switzerland, UK and Italy, Arithmos’ growing geographical expansion continues to shape the firms future transformation while they provide effective solutions such as strengthening of SME’s consultants across clinical and regulatory business units.
Arithmos appoints Massimo Raineri as Senior Consultant, Clinical Business Partner
Arithmos announces the appointment of Massimo Raineri to the role of Senior Consultant, Clinical Business Partner for the company.
With a Master’s degree in Applied Mathematics, Massimo Raineri has 40 years of experience in the clinical development sector working for the top 5 Pharmaceutical companies across Europe.
Massimo started his career in Pharmaceuticals in 1985 as a consultant at Roche. From this pivotal starting point in Massimo Raineri’s career, he enriched his professional experience working for Actelion since 2001, initially as a consultant then as manager, focusing on innovative solutions to improve clinical processes and to manage the Integration competency. Lastly, Massimo Raineri worked for Janssen from 2018 as Director in the Clinical Solutions Strategies team and head of the Imperia site.
Massimo Raineri is an extremely experienced qualified consultant in the R&D, clinical development, and digital space with a large range of competencies, from development and implementation of digital health platforms to the support of Digital Endpoints, Digital Data Flow, Tokenization, and SAE Reconciliation to cite a few.
An Exciting Future for Arithmos
With the established expertise in safety and regulatory domains, and having Massimo on its side, Arithmos aims to strengthen its market position as leader in digital innovation and clinical solutions. Arithmos’ mission is to continue as a trusted consulting partner in consultancy, technology and services with the aim to support Life Science companies to achieve their goals and expand their business.
Massimo Raineri upon joining Arithmos: “I am thrilled to join Arithmos, this forward-thinking global consultancy firm with Italian and British heritage, and a strong international partner network, leverage my extensive expertise in digital health innovation to accelerate drug development and enhance patient care. I am particularly passionate about exploiting the benefits that wearable devices, data standardization, AI and real-world data are offering to streamline clinical trials, improve patient safety and reduce the environmental impact of healthcare. I am committed to working with the Arithmos team to develop sustainable digital health solutions that address unmet technical and regulatory challenges in the healthcare industry and make a positive impact on the patients and site experience.”
Paolo Morelli, CEO and Founder of Arithmos, added: “I’m extremely pleased to have Massimo joining the Arithmos team. Massimo is a thought leader and subject matter expert (SME) in clinical R&D and is a pioneer of Data Science, Digital Endpoints, Health Data, and Digital Twins. Massimo represents a valuable strategic asset for our consultancy unit and with his profile on the team Arithmos is heading to be position as leader in the clinical and R&D consultancy space”.
Who ‘We’ Are
We are experts in the Life Sciences industry & Technology.
We are a long-standing Partner and Service Provider across Clinical Development, Regulatory and Compliance, Quality Management, Pharmacovigilance, and Medical Affairs domains.
We help pharmaceutical, biotechnology, nutraceutical, medical device, universities, hospitals and non-profit organisations to gain the best business value through technology-enabled solutions and achieve excellence in business operations.
